Literature DB >> 18585721

Uric acid: A marker of increased cardiovascular risk.

Ana C M Gagliardi1, Marcio H Miname, Raul D Santos.   

Abstract

The relationship between uric acid and cardiovascular disease has been known since the 19th century, after that many authors reported the classical association of gout, hypertension, obesity and cardiovascular disease. With the exception of specific genetic defects in purine metabolism, increased uric acid is generally associated with important risk factors for atherosclerosis like hypertension, abdominal obesity, insulin resistance, the metabolic syndrome and renal failure. Studies have clearly shown an association between increased uric acid concentrations with oxidative stress, endothelial dysfunction, inflammation, subclinical atherosclerosis and an increased risk of cardiovascular events. Increased uric acid levels are independent markers of cardiovascular disease risk. Prospective studies are necessary to show that reduction of uric acid levels prevent cardiovascular events.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18585721     DOI: 10.1016/j.atherosclerosis.2008.05.022

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  96 in total

1.  Effect of allopurinol in chronic kidney disease progression and cardiovascular risk.

Authors:  Marian Goicoechea; Soledad García de Vinuesa; Ursula Verdalles; Caridad Ruiz-Caro; Jara Ampuero; Abraham Rincón; David Arroyo; José Luño
Journal:  Clin J Am Soc Nephrol       Date:  2010-06-10       Impact factor: 8.237

2.  Sugar-sweetened beverages, serum uric acid, and blood pressure in adolescents.

Authors:  Stephanie Nguyen; Hyon K Choi; Robert H Lustig; Chi-yuan Hsu
Journal:  J Pediatr       Date:  2009-04-17       Impact factor: 4.406

3.  The metabolome profiling and pathway analysis in metabolic healthy and abnormal obesity.

Authors:  H-H Chen; Y J Tseng; S-Y Wang; Y-S Tsai; C-S Chang; T-C Kuo; W-J Yao; C-C Shieh; C-H Wu; P-H Kuo
Journal:  Int J Obes (Lond)       Date:  2015-04-24       Impact factor: 5.095

Review 4.  Uric Acid - key ingredient in the recipe for cardiorenal metabolic syndrome.

Authors:  Kunal Chaudhary; Kunal Malhotra; James Sowers; Annayya Aroor
Journal:  Cardiorenal Med       Date:  2013-10       Impact factor: 2.041

Review 5.  Xanthine oxido-reductase, free radicals and cardiovascular disease. A critical review.

Authors:  A M Robert; L Robert
Journal:  Pathol Oncol Res       Date:  2013-10-15       Impact factor: 3.201

6.  Elevated serum uric acid levels are associated with non-alcoholic fatty liver disease independently of metabolic syndrome features in the United States: Liver ultrasound data from the National Health and Nutrition Examination Survey.

Authors:  Jeffrey C Sirota; Kim McFann; Giovanni Targher; Richard J Johnson; Michel Chonchol; Diana I Jalal
Journal:  Metabolism       Date:  2012-10-02       Impact factor: 8.694

7.  Is lower uric acid level better? A combined cross-sectional and longitudinal study in the elderly.

Authors:  Chang-Hsun Hsieh; Jiunn-Diann Lin; Chung-Ze Wu; Chun-Hsien Hsu; Dee Pei; Yao-Jen Liang; Yen-Lin Chen
Journal:  Endocrine       Date:  2014-02-21       Impact factor: 3.633

8.  Uric acid promotes left ventricular diastolic dysfunction in mice fed a Western diet.

Authors:  Guanghong Jia; Javad Habibi; Brian P Bostick; Lixin Ma; Vincent G DeMarco; Annayya R Aroor; Melvin R Hayden; Adam T Whaley-Connell; James R Sowers
Journal:  Hypertension       Date:  2014-12-08       Impact factor: 10.190

9.  Higher serum uric acid on admission is associated with higher short-term mortality and poorer long-term survival after myocardial infarction: retrospective prognostic study.

Authors:  Sinisa Car; Vladimir Trkulja
Journal:  Croat Med J       Date:  2009-12       Impact factor: 1.351

10.  Uric acid is a strong independent predictor of renal dysfunction in patients with rheumatoid arthritis.

Authors:  Dimitrios Daoussis; Vasileios Panoulas; Tracey Toms; Holly John; Ioannis Antonopoulos; Peter Nightingale; Karen M J Douglas; Rainer Klocke; George D Kitas
Journal:  Arthritis Res Ther       Date:  2009-07-24       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.